He obtained a BSc in Biology from the University of Alicante in 2014, graduating with an Honours Distinction for Academic Achievement, and completed part of his studies at the University of Exeter (UK). He subsequently completed a Master’s degree at the Autonomous University of Barcelona (UAB), where he carried out his Master’s thesis on the nuclear and cytoplasmic effects of coenzyme Q10. Following this, he worked in the private biomedical sector, focusing on human assisted reproduction.
He was later awarded a national FPU fellowship to undertake his PhD studies at the UAB, where his research focused on the role of glucocorticoid receptor signalling pathways in different biological processes related to reproduction and inflammation, with a comparative approach across species. In 2022, he obtained his PhD with an overall grade of Excellent, the highest distinction, Cum Laude, and the International Mention.
He has undertaken several international research stays, including at the UMR Mixte de Nouzilly (Tours, France), a joint research centre of the Centre National de la Recherche Scientifique (CNRS) and the Université de Tours, in 2019, and at the Faculty of Medicine of Linköping University (Sweden) in 2021.
As a postdoctoral researcher, he has worked in preclinical pharmacological research, investigating the effects of repurposed drugs on signalling pathways involved in calcium dyshomeostasis and inflammation, and their role in neurodegenerative diseases.
He has taught at the Department of Animal Health and Anatomy at the Autonomous University of Barcelona, the Department of Physiology, Genetics and Microbiology at the University of Alicante, and the Department of Health Sciences at the European University of Valencia.
To date, his research activity includes participation in several funded national and international research projects and contracts, resulting in 15 scientific publications, including 8 as first author and 13 in Q1 journals, all of them published open access. He has also contributed to more than 40 peer-reviewed conference presentations, most of them at international conferences.
In addition, he regularly contributes to science communication activities for the Spanish Society of Pharmacology and participates in teaching innovation projects, with a particular interest in service-learning methodologies.
Since 2018, he has regularly served as an evaluator for national and regional academic quality-assurance agencies, having participated in more than 15 expert panels.
Since October 2025, he has been an Assistant Professor in Pharmacology in the Department of Optics, Pharmacology and Anatomy at the University of Alicante, where his current research focuses on the inflammatory mechanisms underlying neurodegenerative diseases.
He obtained a BSc in Biology from the University of Alicante in 2014, graduating with an Honours Distinction for Academic Achievement, and completed part of his studies at the University of Exeter (UK). He subsequently completed a Master’s degree at the Autonomous University of Barcelona (UAB), where he carried out his Master’s thesis on the nuclear and cytoplasmic effects of coenzyme Q10. Following this, he worked in the private biomedical sector, focusing on human assisted reproduction.
He was later awarded a national FPU fellowship to undertake his PhD studies at the UAB, where his research focused on the role of glucocorticoid receptor signalling pathways in different biological processes related to reproduction and inflammation, with a comparative approach across species. In 2022, he obtained his PhD with an overall grade of Excellent, the highest distinction, Cum Laude, and the International Mention.
He has undertaken several international research stays, including at the UMR Mixte de Nouzilly (Tours, France), a joint research centre of the Centre National de la Recherche Scientifique (CNRS) and the Université de Tours, in 2019, and at the Faculty of Medicine of Linköping University (Sweden) in 2021.
As a postdoctoral researcher, he has worked in preclinical pharmacological research, investigating the effects of repurposed drugs on signalling pathways involved in calcium dyshomeostasis and inflammation, and their role in neurodegenerative diseases.
He has taught at the Department of Animal Health and Anatomy at the Autonomous University of Barcelona, the Department of Physiology, Genetics and Microbiology at the University of Alicante, and the Department of Health Sciences at the European University of Valencia.
To date, his research activity includes participation in several funded national and international research projects and contracts, resulting in 15 scientific publications, including 8 as first author and 13 in Q1 journals, all of them published open access. He has also contributed to more than 40 peer-reviewed conference presentations, most of them at international conferences.
In addition, he regularly contributes to science communication activities for the Spanish Society of Pharmacology and participates in teaching innovation projects, with a particular interest in service-learning methodologies.
Since 2018, he has regularly served as an evaluator for national and regional academic quality-assurance agencies, having participated in more than 15 expert panels.
Since October 2025, he has been an Assistant Professor in Pharmacology in the Department of Optics, Pharmacology and Anatomy at the University of Alicante, where his current research focuses on the inflammatory mechanisms underlying neurodegenerative diseases.